Produktname:Boc-D-Pyroglutamic Acid Methyl Ester
IUPAC Name:1-tert-butyl 2-methyl (2R)-5-oxopyrrolidine-1,2-dicarboxylate
- CAS:128811-48-3
- Molekulare Formel:C11H17NO5
- Reinheit:95%
- Katalognummer:CM119322
- Molekulargewicht:243.26
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:128811-48-3
- Molekulare Formel:C11H17NO5
- Schmelzpunkt:-
- SMILES-Code:O=C1CC[C@H](C(OC)=O)N1C(OC(C)(C)C)=O
- Dichte:
- Katalognummer:CM119322
- Molekulargewicht:243.26
- Siedepunkt:
- Mdl-Nr.:MFCD07783728
- Lagerung:
Category Infos
- Amino Acids and Peptides
- Amino acids are organic compounds containing a basic amino group and an acidic carboxyl group. Because amino acids contain both amino and carboxyl groups, they can be polymerized in an end-to-end manner, removing a molecule of water to form a covalent amide bond or peptide bond. Many amino acids are linked together end to end to form a polypeptide. Amino acids and peptides are important components in the fields of medicine and life sciences.
- amino acids wholesale
- if you are finding amino acids wholesaler in china, we will be your best choose! We have our own factory, so we can give you a cheap price!
- Pyrrolidines
- Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.
Column Infos
- Vibegron
- Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted a positive opinion recommending approval of OBGEMSA (vibegron under the international non-proprietary name) for the symptomatic treatment of adult patients with overactive bladder syndrome (OAB).
Vibegron is a novel, potent, and selective human beta-3 adrenergic receptor (β3-AR) agonist. Beta receptors are found throughout the body, but β3-ARs are predominantly found on human detrusor smooth muscle. β3-ARs agonists bind to and activate beta-3 receptors on the detrusor muscle, leading to relaxation of the detrusor muscle to increase vesical capacity and to reduce OAB symptoms.